IJIP publishes original research, systematic reviews, implementation studies, outbreak reports, and data resources that advance infection prevention and control. Submissions should demonstrate rigorous methods, clear case definitions, and measurable prevention relevance.

• Title page with author names, affiliations, and corresponding author details
• Structured abstract with objectives, methods, results, and conclusions
• Introduction that defines the IPC context and research gap
• Methods with study design, case definitions, and surveillance protocols
• Results with validated outcomes, effect sizes, and confidence intervals
• Discussion linking findings to prevention practice or policy
• Conclusion highlighting key contributions and future directions

• Use clear headings and consistent terminology
• Define abbreviations and pathogen codes at first use
• Provide units and denominators for rates and metrics
• Include figure legends that describe sample sizes and data sources
• Prepare tables in editable format with clear headings
• Label supplementary files clearly and reference them in the text

• Provide ethics approvals and consent or waiver statements
• Follow CONSORT for trials and STROBE for observational studies
• Use PRISMA for systematic reviews and ORION or SQUIRE when applicable
• Disclose conflicts of interest and funding sources
• Describe limitations and generalizability

Authors should provide data availability statements and, when possible, deposit data in trusted repositories. Code or analysis pipelines should be shared or documented to support reproducibility.

• Include accession numbers or repository links
• Describe preprocessing and quality control steps
• Document software versions and computational environments
• State any access restrictions for sensitive data

• Submit high resolution figures in standard formats
• Label axes and include units for quantitative plots
• Provide color blind friendly palettes when possible
• Ensure tables are editable and include footnotes

• Ensure references are complete and consistent
• Include DOIs where available
• Use standard citation formats
• Confirm all in text citations appear in the reference list

Trials and outbreak evaluations should include registration identifiers when applicable and follow regulatory requirements. Observational studies using registries should describe data governance and consent limitations.

• Provide trial registration numbers when applicable
• Describe primary and secondary endpoints
• Report adverse events and safety monitoring
• Include protocol deviations and amendments

IJIP uses single blind peer review. Reviewers evaluate study rigor, data quality, and clarity of reporting. Initial decisions are typically issued within two to four weeks depending on reviewer availability.

Accepted manuscripts move to production for copyediting, proof review, and DOI registration. Articles are published under CC BY 4.0 to support open access reuse with attribution.

Authors should review proofs promptly to confirm accuracy of figures, tables, and metadata.

APCs are applied after acceptance and cover peer review management, production, and archiving services. Partial waivers may be available for eligible authors. Contact the editorial office for guidance.

• Scope alignment confirmed
• Data availability statement included
• Case definitions and denominators documented
• Cover letter prepared with scope summary
• Ethics and consent statements included

For questions about formatting or submission steps, contact [email protected].

IJIP is committed to rigorous, transparent publishing in infection prevention and control. We emphasize reproducible surveillance methods, clear reporting of case definitions, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in infection prevention science and implementation.